The tumour suppressor gene PTEN (also called MMAC1 or TEP1) is somatically mutated in a variety of cancer types [1-4]. In addition, germline mutation of PTEN is responsible for two dominantly inherited, related cancer syndromes called Cowden disease and Bannayan-Ruvalcaba-Riley syndrome [4] . PTEN encodes a dual-specificity phosphatase that inhibits cell spreading and migration partly by inhibiting integrin-mediated signalling [5] [6] [7] . Furthermore, PTEN regulates the levels of phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) by specifically dephosphorylating position 3 on the inositol ring [8] . We report here that the dauer formation gene daf-18 is the Caenorhabditis elegans homologue of PTEN. DAF-18 is a component of the insulin-like signalling pathway controlling entry into diapause and adult longevity that is regulated by the DAF-2 receptor tyrosine kinase and the AGE-1 PI 3-kinase [9] . Others have shown that mutation of daf-18 suppresses the life extension and constitutive dauer formation associated with daf-2 or age-1 mutants. Similarly, we show that inactivation of daf-18 by RNA-mediated interference mimics this suppression, and that a wild-type daf-18 transgene rescues the dauer defect. These results indicate that PTEN/DAF-18 antagonizes the DAF-2-AGE-1 pathway, perhaps by catalyzing dephosphorylation of the PIP 3 generated by AGE-1. These data further support the notion that mutations of PTEN contribute to the development of human neoplasia through an aberrant activation of the PI 3-kinase signalling cascade. 
Results and discussion
We identified a cosmid (T07A9) and an expressed sequence tag (EST; yk400b8) that encode a putative C. elegans homologue of the mammalian PTEN gene (Figure 1a) . The C. elegans gene is located on the left arm of chromosome IV, between daf-1 and opu- 18 . Complete sequence analysis of the yk400b8 cDNA (the cDNA was kindly provided by Yuji Kohara) revealed a 962 amino-acid open-reading frame (see Supplementary material published with this paper on the internet); a 180 amino-acid region of this predicted protein has significant sequence similarity (46% identity) with the tensin/phosphatase domain of PTEN ( Figure 1b) . A multiple sequence alignment of PTEN homologues shows that the phosphatase signature motifs known to be essential for catalysis are conserved in the C. elegans PTEN homologue (see Supplementary material); for example, one conserved (a) Physical map of the C. elegans PTEN gene (Genbank accession number AF036706). The exon-intron structure was determined by comparing genomic DNA and cDNA sequences; the seven exons are depicted as boxes with shading indicating the coding sequence. The sequence of the cDNA (EMBL accession number AJ131181) showed that the 3′ end of exon 5 is 9 bp upstream of the position predicted by Genefinder (T07A9.6, accession number 044405). The daf-18(e1375) mutation was identified by sequencing polymerase chain reaction products amplified from genomic DNA isolated from daf-18(e1375) mutant animals. This mutation was found to consist of an insertion of 30 nucleotides combined with the deletion of 2 nucleotides within exon 4. The insertion is composed of two repeats of 11 nucleotides (TGCGTTGACTC) and of an incomplete repeat GTTGAC. sequence is HCXAGXXR (in single-letter amino-acid code, where X represents any amino acid), which contains the cysteine involved in forming the thiol-phosphate bond with the substrate [10] . Constructing a phylogenetic tree of the tensin family shows that the C. elegans PTEN homologue is more closely related to mammalian PTEN than to other members of this family (see Supplementary material). Therefore, the high conservation of the catalytic core sequence across evolution suggests that C. elegans PTEN has an enzymatic activity similar to its mammalian counterparts.
Given the capacity of PTEN to dephosphorylate PIP 3 at position 3 on the inositol ring [8] , we reasoned that the C. elegans PTEN homologue might antagonize the function of the PI 3-kinase AGE-1 [11] . The age-1 gene is involved in the genetic pathway controlling the formation of dauer larvae, the rate of ageing and the resistance to oxidative and UV stress and to thermotolerance [11] [12] [13] [14] [15] [16] ; mutations in age-1 lead to constitutive dauer formation [13] [14] [15] . Therefore, a simple model would predict that a mutation in the C. elegans PTEN homologue should lead to a dauer-defective phenotype -the opposite effect of age-1 mutants. Previous studies have shown that a daf-18 mutant is defective in dauer formation, and epistatic analyses have demonstrated that mutation of daf-18 inhibits dauer formation caused by the age-1(m333) mutant and suppresses life-span extension caused by age-1(hx546) [12] [13] [14] [15] . Furthermore, the daf-18 gene is located on chromosome IV and maps to a region compatible with the position of the PTEN homologue. On the basis of these arguments, daf-18 was considered to be an excellent candidate for the C. elegans PTEN. We therefore sequenced the PTEN gene in the daf-18 mutant strain CB1375 and found an insertion of 30 base pairs in exon 4 ( Figure 1a ) that results in the addition of six amino acids followed by a premature stop codon immediately after amino acid 563 (Figure 1b ). This mutation falls outside the phosphatase domain and is predicted either to truncate the PTEN/DAF-18 protein or to lead to destabilization of the transcript or protein.
The daf-2 gene encodes a member of the insulin receptor family that is implicated in the genetic pathway controlling dauer formation and the rate of ageing [13] [14] [15] [16] [17] [18] [19] [20] . Genetic epistasis interactions place the daf-2(e1370, m65) mutant upstream of daf-18 for life-span determination [14, 15] ; the order of these two genes in the pathway regulating dauer formation is somewhat ambiguous, however, because daf-2(e1370) daf-18 double mutants can enter, and rapidly exit, the dauer state [14, 21] . To explore the role of PTEN/daf-18 in the daf-2-mediated control of diapause, we used RNA interference (RNAi) [22] to inactivate PTEN/daf-18 expression in daf-2(e1368) and age-1(mg44) mutants. As shown in Table 1 , daf-2 mutants from parents injected with the unrelated tra-2 doublestranded interfering RNA (dsRNA) and grown at the restrictive temperature arrested as dauers, whereas 68% of those from daf-2 parents injected with PTEN/daf-18 dsRNA gave rise to adults. Similarly, RNAi inhibition of PTEN/daf-18 in age-1(mg44) mutants resulted in an almost complete rescue of the age-1 phenotype: 92% of the progeny of injected worms proceeded to the adult stage (Table 2) . Finally, we showed that a wild-type daf-18 transgene is capable of rescuing daf-18 in a daf-2(e1368) daf-18 double mutant, which is dauer-defective. In this mutant background, the ability of a transgene to restore dauer formation at the restrictive temperature is an indicator of daf-18 rescue. As shown in Table 3 , 30% of PTEN/daf-18 dsRNA was synthesized using a subclone of the yk400b8 cDNA as a template, and 2 mg/ml of this dsRNA was injected into six adult daf-2(e1368) hermaphrodites. Control daf-2(e1368) animals were left uninjected or injected with the tra-2 dsRNA. The animals were grown at the permissive temperature (15°C) then shifted to 25.5°C after injection. They were transferred to a fresh plate 12-18 h after injection and then subsequently transferred at 24 h intervals. All the F1 progeny born from injected animals were scored for phenotype, therefore the effect of RNAi was underestimated as animals produced by eggs not affected by RNAi at the time of injection were also scored for phenotype. N represents the total number of F1 animals scored after injection. Dysregulation of the PI 3-kinase pathway has clearly been involved in the transformation process mediated by various oncogenes [24] . Also, amplification of PIK3CA, which encodes the catalytic subunit of PI 3-kinase, has been characterized in a frequent proportion of ovarian cancers, and amplification of Akt2 has been characterized in a fraction of ovarian, pancreatic and breast cancers [25] [26] [27] . Our data underscore the key role that PTEN/DAF-18 might have in the regulation of the PI 3-kinase-AKT pathway and strongly support the notion that inactivating mutations of PTEN in human tumours are likely to result in an aberrant stimulation of Akt and downstream effectors -a model substantiated by several recent studies [28] [29] [30] . While this work was being submitted for publication, Ogg and Ruvkun [31] also reported similar findings, namely that DAF-18 is a C. elegans PTEN homologue that acts in the insulin-like receptor signalling pathway.
Supplementary material
The sequence of the predicted PTEN homologue protein deduced from the sequence of the full-length cDNA yk400b8, an alignment of the tensin/phosphatase domain with members of the PTEN family, a phylogenetic tree of the tensin family, and additional methodological details are published with this paper on the internet. 
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